Broadview Ventures Appoints Cardiovascular Leader and Biotech Executive Michael Mendelsohn, MD to its Strategic Advisory Board
BOSTON – November 30, 2022 – Broadview Ventures, a mission-driven, cardiovascular health-focused investment organization, today announced...